The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 755.00
Bid: 751.00
Ask: 751.20
Change: -1.00 (-0.13%)
Spread: 0.20 (0.027%)
Open: 756.00
High: 767.00
Low: 748.00
Prev. Close: 756.00
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Expiration of DFS Monitorship

21 Nov 2018 16:38

RNS Number : 1241I
Standard Chartered PLC
21 November 2018
 

Expiration of DFS Monitorship

 

LONDON, 21 November, 2018 - Standard Chartered PLC (the "Group") announces that the term of the monitorship appointed by the New York State Department of Financial Services ("DFS") will expire on 31 December 2018 as part of a Second Supplemental Consent Order (the "Order") agreed between the DFS and Standard Chartered Bank, New York Branch (the "Bank").

 

The Order outlines the parties' agreement that to facilitate continued progress towards objectives of the 2012 and 2014 Consent Orders, beginning on 1 January 2019 the Bank shall engage an independent consultant, selected by the DFS, for a period of up to one year (with a possible extension of one additional year) to provide guidance to the Bank in connection with tasks necessary to complete the remediation contemplated by the 2012 and 2014 Consent Orders.

 

The Order acknowledges that the Bank has demonstrated its commitment to complying with state and federal anti-money laundering and sanctions laws and regulations and has substantially remediated and enhanced its Bank Secrecy Act/anti-money laundering compliance program.The Group is pleased that the DFS has acknowledged the Bank's progress in remediating and improving its financial crime controls to the point that a monitor is no longer necessary. The Group and the Bank remain committed to completing the remaining tasks necessary for that remediation.

 

The Bank entered into the first Consent Order related to dealings with Iranian entities in September 2012 and the second Consent Order, related to deficiencies in anti-money laundering controls at the Bank, in August 2014. The first Supplemental Consent Order, agreed to in April 2017, extended the term of the Consent Orders (and the term of the DFS-appointed monitor) until 31 December 2018.

 

The Order does not affect the status of the investigation into US sanctions compliance as disclosed in the Group's annual and half-year reports. The Group will provide further updates regarding any resolution of that investigation as circumstances warrant.

 

For further information, please contact:

 

Mark Stride - Investor queries

mark.stride@sc.com 

+44 (0)20 7885 8596

 

Julie Gibson - Media queries

julie.gibson@sc.com

+44 (0)20 7885 2434

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCPGGQWGUPRGQG
Date   Source Headline
15th Mar 202410:30 amRNSHolding(s) in Company
14th Mar 20246:05 pmRNSTransaction in Own Shares
14th Mar 20242:03 pmRNSTotal Voting Rights
14th Mar 202411:05 amRNSDirector/PDMR Shareholding
13th Mar 20246:02 pmRNSTransaction in Own Shares
13th Mar 20246:00 pmRNSPublication of Supplementary Prospectus
13th Mar 202411:26 amRNSOverseas Regulatory Announcement – Grant of awards
13th Mar 202410:45 amRNSDirector/PDMR Shareholding
12th Mar 20246:00 pmRNSTransaction in Own Shares
12th Mar 20242:54 pmRNSDirector/PDMR Shareholding
12th Mar 202410:57 amRNSOverseas Regulatory Announcement - Grant of awards
12th Mar 202410:00 amRNSStandard Chartered: Management Team Change
11th Mar 20246:23 pmRNSTransaction in Own Shares
8th Mar 20245:59 pmRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20246:02 pmRNSTransaction in Own Shares
6th Mar 202411:33 amRNSNotice of Redemption
5th Mar 20246:15 pmRNSTransaction in Own Shares
4th Mar 20246:04 pmRNSTransaction in Own Shares
1st Mar 20245:50 pmRNSTransaction in Own Shares
1st Mar 202412:00 pmRNSTotal Voting Rights
29th Feb 20246:15 pmRNSTransaction in Own Shares
29th Feb 20244:21 pmRNSPublication of Final Terms
29th Feb 20247:00 amRNSIssuance of U.S.$1bn Additional Tier 1 Securities
29th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20246:09 pmRNSTransaction in Own Shares
26th Feb 202410:03 amRNSShare Buy-Back
23rd Feb 20242:39 pmRNSFull Year 2023 Pillar 3 Disclosures
23rd Feb 202412:13 pmRNSPublication of Supplementary Prospectus
23rd Feb 20247:00 amRNSAnnual Report 2023
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 2
23rd Feb 20247:00 amRNSAdditional Financial Information - Part 1
23rd Feb 20247:00 amRNSSCPLC Final Results 2023
16th Feb 202410:00 amRNSDirectorate Changes
8th Feb 202411:07 amRNSOverseas Regulatory Announcement
1st Feb 202410:26 amRNSTotal Voting Rights
26th Jan 202412:28 pmRNSDirector/PDMR Shareholding
17th Jan 202412:33 pmRNSPublication of Final Terms
5th Jan 202412:04 pmRNSPublication of Final Terms
2nd Jan 20243:33 pmRNSTotal Voting Rights
28th Dec 202311:22 amRNSPublication of Supplementary Prospectus
27th Dec 202312:36 pmRNSNotice of Redemption
21st Dec 20231:00 pmRNSDirectorate Change
1st Dec 202311:56 amRNSBlock listing Interim Review
1st Dec 202310:37 amRNSTotal Voting Rights
29th Nov 20231:42 pmRNSSCPLC Sustainability Investor Event
22nd Nov 20239:17 amRNSOverseas Regulatory Announcement
21st Nov 202310:28 amRNSOverseas Regulatory Announcement - Grant of Awards
9th Nov 202310:01 amRNSNotice of Redemption
8th Nov 20239:00 amRNSNotice of Redemption

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.